Safety and Efficacy of Sovateltide (IRL-1620) in a Multicenter Randomized Controlled Clinical Trial in Patients with Acute Cerebral Ischemic Stroke
2021 · CNS Drugs · 42 citations
https://doi.org/10.1007/s40263-020-00783-9
A
Anil Gulati
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
5
Papers
27
Citations
2
h-index
2
i10-index
Anil Gulati is an academic researcher from Salisbury University. The author has contributed to research in topics: Psychological and Educational Research Studies & Business Process Modeling and Analysis & Information Technology Governance and Strategy. The author has an h-index of 2, co-authored 5 publications.
Papers by this author
worksA Multicentric, Randomized, Controlled Phase III Study of Centhaquine (Lyfaquin®) as a Resuscitative Agent in Hypovolemic Shock Patients
2021 · Drugs · 19 citations
https://doi.org/10.1007/s40265-021-01547-5
Efficacy and Safety of Sovateltide in Patients with Acute Cerebral Ischaemic Stroke: A Randomised, Double-Blind, Placebo-Controlled, Multicentre, Phase III Clinical Trial
2024 · Drugs · 4 citations
https://doi.org/10.1007/s40265-024-02121-5
Sovateltide (IRL-1620) activates neuronal differentiation and prevents mitochondrial dysfunction in adult mammalian brains following stroke
2020 · Scientific Reports · 29 citations
https://doi.org/10.1038/s41598-020-69673-w
Centhaquin attenuates hyperalgesia and non-evoked guarding in a rat model of postoperative pain primarily through α 2B -adrenoceptors
2016 · European Journal of Pharmacology · 7 citations
https://doi.org/10.1016/j.ejphar.2016.07.016
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat